title: Persistent enteric murine norovirus infection is associated with functionally suboptimal virus-specific CD8 T cell responses.
abstract: Norovirus (NV) gastroenteritis is a major contributor to global morbidity and mortality, yet little is known about immune mechanisms leading to NV control. Previous studies using the murine norovirus (MNV) model have established a key role for T cells in MNV clearance. Despite these advances, important questions remain regarding the magnitude, location, and dynamics of the MNV-specific T cell response. To address these questions, we identified MNV-specific major histocompatibility complex (MHC) class I immunodominant epitopes using an overlapping peptide screen. One of these epitopes (amino acids 519 to 527 of open reading frame 2 [ORF2(519-527)]) was highly conserved among all NV genogroups. Using MHC class I peptide tetramers, we tracked MNV-specific CD8 T cells in lymphoid and mucosal sites during infection with two MNV strains with distinct biological behaviors, the acutely cleared strain CW3 and the persistent strain CR6. Here, we show that enteric MNV infection elicited robust T cell responses primarily in the intestinal mucosa and that MNV-specific CD8 T cells dynamically regulated the expression of surface molecules associated with activation, differentiation, and homing. Furthermore, compared to MNV-CW3 infection, chronic infection with MNV-CR6 resulted in fewer and less-functional CD8 T cells, and this difference was evident as early as day 8 postinfection. Finally, MNV-specific CD8 T cells were capable of reducing the viral load in persistently infected Rag1(-/-) mice, suggesting that these cells are a crucial component of NV immunity. Collectively, these data provide fundamental new insights into the adaptive immune response to two closely related NV strains with distinct biological behaviors and bring us closer to understanding the correlates of protective antiviral immunity in the intestine.
authors.affiliation: Department of Medicine, Division of Gastroenterology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
authors.forename: Vesselin T
authors.initials: VT
authors.lastname: Tomov
authors.forename: Lisa C
authors.initials: LC
authors.lastname: Osborne
authors.forename: Douglas V
authors.initials: DV
authors.lastname: Dolfi
authors.forename: Gregory F
authors.initials: GF
authors.lastname: Sonnenberg
authors.forename: Laurel A
authors.initials: LA
authors.lastname: Monticelli
authors.forename: Kathleen
authors.initials: K
authors.lastname: Mansfield
authors.forename: Herbert W
authors.initials: HW
authors.lastname: Virgin
authors.forename: David
authors.initials: D
authors.lastname: Artis
authors.forename: E John
authors.initials: EJ
authors.lastname: Wherry
mesh_terms: D000818:Animals; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D017250:Caliciviridae Infections / Q000276:immunology* / Q000821:virology; D002908:Chronic Disease; D018984:Epitopes, T-Lymphocyte; D005260:Female; D005434:Flow Cytometry; D005759:Gastroenteritis / Q000276:immunology* / Q000821:virology; D016056:Immunodominant Epitopes; D007413:Intestinal Mucosa / Q000276:immunology / Q000821:virology; D008213:Lymphocyte Activation; D008285:Major Histocompatibility Complex; D051379:Mice; D008810:Mice, Inbred C57BL; D029322:Norovirus / Q000276:immunology*
chemical_list: D018984:Epitopes, T-Lymphocyte; D016056:Immunodominant Epitopes